Focal Segmental Glomerulosclerosis (FSGS) Global Clinical Trials Review, H2, 2017

2017-08-23
Price :
Published : Aug-2017
No. of Pages : 76
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Focal Segmental Glomerulosclerosis (FSGS) to Genito Urinary System And Sex Hormones Clinical Trials 16
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Focal Segmental Glomerulosclerosis (FSGS) to Genito Urinary System And Sex Hormones Clinical Trials 20
Clinical Trials by Phase in E7 Countries 22
Clinical Trials in E7 Countries by Trial Status 23
Clinical Trials by Phase 24
In Progress Trials by Phase 25
Clinical Trials by Trial Status 26
Clinical Trials by End Point Status 27
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Focal Segmental Glomerulosclerosis (FSGS) Therapeutics Clinical Trials 32
Prominent Drugs 34
Latest Clinical Trials News on Focal Segmental Glomerulosclerosis (FSGS) 35
Jun 06, 2017: Oral Presentation at ERA-EDTA Congress Highlights Potential for CCR2 Inhibition in Focal Segmental Glomerulosclerosis 35
May 25, 2017: Retrophin Announces Presentations On Late-Stage Clinical Development Program Sparsentan at Upcoming Medical Congress 35
Clinical Trial Profile Snapshots 36
Appendix 74
Abbreviations 74
Definitions 74
Research Methodology 75
Secondary Research 75
About GlobalData 76
Contact Us 76
Source 76

List of Tables
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics, Global, Clinical Trials by Region, 2017* 7
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 14
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 15
Proportion of Focal Segmental Glomerulosclerosis (FSGS) to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2017* 17
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19
Proportion of Focal Segmental Glomerulosclerosis (FSGS) to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2017* 21
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 22
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 23
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics, Global, Clinical Trials by Phase, 2017* 24
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 25
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 26
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 27
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 28
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 29
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 31
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 33
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 34

List of Figures
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
Proportion of Focal Segmental Glomerulosclerosis (FSGS) to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2017* 16
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19
Proportion of Focal Segmental Glomerulosclerosis (FSGS) to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2017* 20
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 22
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 23
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics, Global, Clinical Trials by Phase (%), 2017* 24
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 25
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 26
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 27
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 28
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 29
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 30
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 32
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 34
GlobalData Methodology 75
Filed in: Pharmaceutical
Publisher : GlobalData